Molecular and neuroimaging biomarkers of Alzheimer’s disease at #SfN16 | PLOS Neuroscience Community
This year’s Society for Neuroscience (SfN) conference was rich with emerging advances in the detection of neuropathological changes that occur during Alzheimer’s disease. The cutting edge of this research was presented at the nanosymposium on Molecular and Neuroimaging Biomarkers of Alzheimer’s Disease Saturday afternoon. From genetics to brain structure to molecular markers, this session highlighted the diversity of tools researchers are employing to better understand the neural effects of both normal and pathological aging.
Continue Reading http://blogs.plos.org
Join the Discussion